JYOTHY LABS LIMITED
₹172.05-₹3.30 (-1.9%)
Last close · Data as of Oct 30, 2026
- Market cap
- ₹9,555 Cr
- P/E
- 27.2x
- EV / EBITDA
- 17.6x
- Revenue
- ₹2,844 Cr
- Net margin
- 13.4%
- ROCE
- 40.2%
Price chart
Technical chartScreen technicals →-46.3% over the last year
Daily closes.
Go deeper
Technical chart: candles, 9 moving averages, RSI, MACD and drawing tools
Performance
Price change over each period, before dividends.
- 1M
- -7.8%
- 3M
- -15.1%
- 6M
- -35.2%
- 1Y
- -46.3%
- 5Y
- +8.8%
52-week range
Day change -₹3.30 (-1.9%) from ₹175 to ₹172 · Last close Oct 30, 2026
Best weekday to invest, historically
The same weekly amount in JYOTHYLAB, bought on each weekday since 2021.
AI Summary
Indian StockStrengths1
- Strong 5-year net profit CAGR of 18.6%
Concerns0
Rule-based from financial data. Not advice.
About the company
Jyothy Labs Limited, together with its subsidiaries, manufactures and markets fabric care, dishwashing, personal care, and household insecticides products in India and internationally. It operates through Dishwashing, Fabric Care, Household Insecticides, Personal Care, and Others segments.
Read moreShow less
Jyothy Labs Limited, together with its subsidiaries, manufactures and markets fabric care, dishwashing, personal care, and household insecticides products in India and internationally. It operates through Dishwashing, Fabric Care, Household Insecticides, Personal Care, and Others segments. The Dishwashing segment offers dish wash bars, gels, and liquids, as well as dish wash scrubbers, steel scrubbers, and powders under the Pril and Exo brands. The Fabric Care segment provides fabric whiteners, enhancers, and conditioner; detergent powders; and detergent liquids and bar soaps under the Henko, Mr. White, Ujala, and More light brands. The Household Insecticides segment offers mosquito repellent coils, aerosol, liquids, and racquet, as well as surface cleaners and air care products under the Maya, T- Shine, and Maxo brands. The Personal Care segment provides body soaps, toothpastes, deodorants, talcum powders, after shave products, and hand washes under the Margo, FA, and Neem Active brands. The Others segment offers incense sticks under the Maya brand; and toilet and floor cleaner products. The company also provides dry cleaning and laundry services under the Fabric Spa brand. The company was formerly known as Jyothy Laboratories Limited and changed its name to Jyothy Labs Limited in July 2019. Jyothy Labs Limited was founded in 1983 and is based in Mumbai, India.
- Sector
- Healthcare
- Shares outstanding
- 36.8 Cr shares
- ISIN
- INE668F01031
- BSE code
- 532926
Key statistics
Screen fundamentals →Valuation, profitability, growth and solvency at the latest close; hover a label for its meaning.
Valuation
- Market cap
- ₹9,555 Cr
- P/E
- 27.2x
- P/B
- 6.6x
- EV / EBITDA
- 17.6x
- EV / Sales
- 3.4x
- P/S
- 3.5x
- Earnings yield
- 3.7%
- 52-week high
- ₹321.00
- 52-week low
- ₹172.05
Profitability
- Operating margin
- 17.4%
- Net margin
- 13.4%
- EBITDA margin
- 19.4%
- ROE
- 32.4%
- ROCE
- 40.2%
- ROA
- 21.4%
- Dividend payout
- 35.0%
- Tax rate
- 23.0%
- Other income, % of PBT
- 11.3%
Growth
- RevenueLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- ₹2,844 Cr
- Revenue growth, 1YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- 3.3%
- Revenue CAGR, 5YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- 10.6%
- EBITDALatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- ₹534 Cr
- EBITDA growth, 1YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- 47.1%
- Net profit growth, 1YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- 0.3%
- Net profit CAGR, 5YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- 18.6%
- Cash from operationsLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- ₹458 Cr
- CFO growth, 1YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- 39.2%
- Free cash flowLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- -₹7.00 Cr
- Asset growth, 1YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- 24.4%
Solvency and efficiency
- Current ratio
- 2.36
- Debt / Equity
- 0.04
- Debt / Assets
- 0.03
- Debt / EBITDA
- 0.10
- Interest coverage
- 96.00
- Financial leverage
- 1.52
- CFO / Net profit
- 1.24
- Cash / Market cap
- 11.3%
- Cash per share
- ₹29.31
- Asset turnover
- 1.59
- Fixed asset turnover
- 6.20
- Capital intensity
- 0.16
- Debtor days
- 26 days
- Inventory turnover
- 5.00
- Cash conversion cycle
- 28 days
Where the revenue went
Of every ₹100 of FY2025 revenue, ₹13 was left as net profit.
| From | To | Amount |
|---|---|---|
| Sales | Expenses | ₹2,344 Cr |
| Sales | Operating profit | ₹500 Cr |
| Operating profit | Interest | ₹6 Cr |
| Operating profit | Depreciation | ₹56 Cr |
| Operating profit | Profit before tax | ₹438 Cr |
| Other income | Profit before tax | ₹51 Cr |
| Profit before tax | Tax and other | ₹119 Cr |
| Profit before tax | Net profit | ₹371 Cr |
Revenue and net profit
Revenue grew 3.3% in FY2025; net profit is the dashed line.
| Date | Revenue | Net profit |
|---|---|---|
| FY2021 | ₹1,885 Cr | ₹190 Cr |
| FY2022 | ₹2,193 Cr | ₹139 Cr |
| FY2023 | ₹2,482 Cr | ₹240 Cr |
| FY2024 | ₹2,754 Cr | ₹370 Cr |
| FY2025 | ₹2,844 Cr | ₹371 Cr |
Cash flows
FY2025: ₹312 Cr from operations, ₹151 Cr free after investment (dashed).
| Date | Operating cash flow | Free cash flow |
|---|---|---|
| FY2021 | ₹408 Cr | ₹259 Cr |
| FY2022 | ₹201 Cr | ₹172 Cr |
| FY2023 | ₹329 Cr | ₹281 Cr |
| FY2024 | ₹458 Cr | ₹114 Cr |
| FY2025 | ₹312 Cr | ₹151 Cr |
Growth
Latest fiscal year FY2025 (ending March): each figure with its change over the year before.
- Revenue
- ₹2,844 Cr+3.3%1Y
- Net profit
- ₹371 Cr+0.3%1Y
- Cash from operations
- ₹312 Cr
- Free cash flow
- ₹151 Cr+32.5%1Y
- Revenue CAGR, 5Y
- 10.6%
- EBITDA CAGR, 5Y
- 15.0%
- Net profit CAGR, 5Y
- 18.6%
| Year | Revenue | Operating income | EBITDA | Net profit | CFO | FCF | ROE | Revenue growth 1Y | Net profit growth 1Y |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | ₹2,844 Cr | ₹500 Cr | — | ₹371 Cr | ₹312 Cr | ₹151 Cr | 26.8% | +3.3% | +0.3% |
Monthly returns
Month-by-month returns of JYOTHYLAB across the years, with the seasonal pattern.
Balance sheet
What the company owns and owes at the end of FY2025.
| Line | FY2025 |
|---|---|
| Liabilities and equity | ₹2,024 Cr |
| Equity capital | ₹37 Cr |
| Reserves | ₹1,346 Cr |
| Borrowings | ₹61 Cr |
| Other liabilities | ₹580 Cr |
| Assets | ₹2,024 Cr |
| Fixed assets | ₹460 Cr |
| Capital work in progress | ₹22 Cr |
| Investments | ₹456 Cr |
| Other assets | ₹1,085 Cr |
Market cap against peers
8 peers: same sector group, nearest by size.
P/E against peers
JYOTHYLAB trades at 27.2x earnings against a peer median of 52.6x (a 48% discount).
Peer comparison
Same-sector peers by market cap, with the median.
| Company | Market cap | P/E | P/B | ROE | EV/EBITDA |
|---|---|---|---|---|---|
| JYOTHY LABS LIMITEDJYOTHYLABthis companyP/E ↓ discount | ₹9,555 Cr | 27.2x | 6.6x | 32.4% | 17.6x |
| Vijaya Diagnostic Centre LimitedVIJAYA | ₹10,297 Cr | 69.2x | 12.1x | 17.6% | 45.6x |
| Metropolis Healthcare LimitedMETROPOLIS | ₹9,882 Cr | 74.0x | 7.4x | 11.3% | 36.5x |
| Sanofi Consumer Healthcare India LimitedSANOFICONR | ₹9,742 Cr | 45.3x | 37.8x | — | — |
| HealthCare Global Enterprises LimitedHCG | ₹9,408 Cr | 513.0x | 8.0x | 2.8% | 49.9x |
| Sanofi India LtdSANOFI | ₹9,387 Cr | 25.4x | 12.0x | — | — |
| Jeena Sikho Lifecare LimitedJSLL | ₹8,968 Cr | 58.2x | 25.2x | 35.9% | 90.3x |
| PROCTER & GAMBLE HEALTH LIMITEDPGHL | ₹8,946 Cr | 29.2x | 14.4x | — | — |
| Jupiter Life Line Hospitals LimitedJLHL | ₹8,877 Cr | 46.3x | 5.9x | 12.2% | 34.5x |
| Peer median | — | 52.6x | 5.9x | 12.1% | 38.3x |
Year-to-date ROI
JYOTHYLAB since 1 January, against earlier years.
Historical volatility
JYOTHYLAB's day-to-day swings over 30, 60 and 180 days.
Financial statements
Income statement, balance sheet and cash flow as reported, in ₹ crore, grouped into plain-language lines.
Figures in ₹ crore as reported, fiscal years ending March, newest first; the trailing twelve months (TTM) last.
Operating margin by fiscal year
| Date | Operating margin |
|---|---|
| FY2021 | 17.0% |
| FY2022 | 11.0% |
| FY2023 | 13.0% |
| FY2024 | 17.0% |
| FY2025 | 18.0% |
| Line | FY2025 |
|---|---|
| RevenueSales | ₹2,844 Cr |
| Costs | |
| Interest | ₹6 Cr |
| Expenses | ₹2,344 Cr |
| Operating profitOperating Profit | ₹500 Cr |
| Other income and charges | |
| Profit before tax | ₹490 Cr |
| Tax | |
| Net profitNet Profit | ₹371 Cr |
| Per share |
| Line | FY2025 |
|---|---|
| Liabilities and equityTotal Liabilities | ₹2,024 Cr |
| Equity capitalEquity Capital | ₹37 Cr |
| Reserves | ₹1,346 Cr |
| Borrowings | ₹61 Cr |
| Other liabilitiesOther Liabilities | ₹580 Cr |
| AssetsTotal Assets | ₹2,024 Cr |
| Fixed assetsFixed Assets | ₹460 Cr |
| Capital work in progressCWIP | ₹22 Cr |
| Investments | ₹456 Cr |
| Other assetsOther Assets | ₹1,085 Cr |
| Line | FY2025 |
|---|---|
| Operating cash flowCash from Operating Activity | ₹312 Cr |
| Investing cash flowCash from Investing Activity | -₹161 Cr |
| Financing cash flowCash from Financing Activity | -₹157 Cr |
| Change in cashNet Cash Flow | -₹7 Cr |
Learn while you research
Academy chapters picked for JYOTHY LABS LIMITED and the metrics on this page.
- 01 Taxes on Investments (India)LTCG, STCG, dividend tax, what every Indian investor needs.6 min read
- 02 Stock Valuation BasicsHow to think about what a fair price for a stock looks like.7 min read
- 03 Stock Market RisksSmall caps carry concentrated, idiosyncratic risk, learn to manage it.6 min read
- 04 Sector Analysis MattersHealthcare valuation is driven by pipelines and regulation, not just numbers.6 min read
- 05 Essential Stock RatiosP/E, P/B, EV/EBITDA, what they mean and when to use each.7 min read
- 06 How to Read a Cash-Flow StatementProfit can be manipulated; cash flow rarely lies.7 min read